News

Implantable ARC therapy demonstrates potential to improve blood pressure regulation ONWARD – a company which creates therapies to restore movement in people with spinal cord injury (SCI) – has ...
Onward’s ARC-EX delivers targeted, programmed spinal cord stimulation non-invasively, rather than via implanted electrodes. This means the technology does not need surgery to be administered ...
During today’s surgery, the ARC-IM Lead was placed in the “Hemodynamic Hotspot” along the thoracic spinal cord, an area in which targeted electrical stimulation may restore better blood ...
Onward Medical NV reported initial patient enrollment in its Hemon early feasibility study and first-in-human trial of its ARC implantable pulse generator. The study will examine stabilization of ...
Onward’s ARC-EX delivers targeted, programmed spinal cord stimulation non-invasively, rather than via implanted electrodes. This means the technology does not need surgery to be administered ...
ONWARD ARC Therapy, which can be delivered by implantable (ARC-IM) or external (ARC-EX ®) systems, is designed to deliver targeted, programmed spinal cord stimulation to restore movement and ...